創薬におけるAIの世界市場2020-2027:治療領域別(腫瘍、心血管疾患、代謝性疾患)、用途別、地域別

◆英語タイトル:Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology, Cardiovascular Disease, Metabolic Diseases), By Application, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV036
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年9月8日
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、創薬におけるAIの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、用途別市場規模(医薬品最適化・転用、前臨床試験、その他)、治療領域別市場規模(腫瘍、心血管疾患、代謝性疾患、感染症、その他)、地域別市場規模、競争分析、企業概要などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・創薬におけるAIの世界市場規模:用途別(医薬品最適化・転用、前臨床試験、その他)
・創薬におけるAIの世界市場規模:治療領域別(腫瘍、心血管疾患、代謝性疾患、感染症、その他)
・創薬におけるAIの世界市場規模:地域別
・競争分析
・企業概要
【レポートの概要】

Artificial Intelligence In Drug Discovery Market Growth & Trends

The global artificial intelligence in drug discovery market size is expected to reach USD 3.5 billion by 2027, expanding at a CAGR of 28.8%, according to a new report by Grand View Research, Inc. The growing adoption of artificial intelligence (AI) platforms aimed at reducing the overall cost associated with drug discovery and to enhance results is expected to propel the demand for these platforms in the pharma market.

Based on the application, the drug optimization and repurposing segment accounted for the largest revenue share in 2019. AI platforms help in identifying alternative applications for existing medicines. This can help pharma companies diversify their portfolio of offerings and assist in producing alternative therapies through minor alterations in the pharmaceutical product. Furthermore, AI platforms also enable researchers to identify the toxic effects of the medicine on the body and thus reduce the chances of adverse effects.

In 2019, oncology application accounted for the largest share whereas, the infectious disease application segment is expected to emerge as the fastest-growing application segment over the forecast period. Artificial intelligence already plays a vital role in the early detection of cancer. Furthermore, as treatments for cancer may vary for each patient, personalized medicine has proven to be an effective alternative.

North America dominated the market with a revenue share of 59.4% in 2019 owing to the increasing adoption of artificial intelligence and the presence of a large number of market players. Asia Pacific is expected to emerge as the fastest-growing region in the market over the forecast period. The growing adoption of new technology in India and China for new drug development and a focus towards boosting pharmaceutical capacities within the countries is expected to drive the market in the region.

Artificial Intelligence In Drug Discovery Market Report Highlights

• The drug optimization and repurposing segment accounted for the largest revenue share of 54.4% in 2019

• By therapeutic area, the oncology segment was valued at USD 125.0 million in 2019

• By therapeutic area, the infectious disease segment is expected to witness the fastest growth of 31.4% from 2020 to 2027

• In Asia Pacific, the AI in drug discovery market is expected to witness a CAGR of 32.1% from 2020 to 2027

• North America and Europe together accounted for 78.6% share of the market revenue in 2019.

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Global AI in Drug Discovery Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 AI in Drug Discovery Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Global AI in Drug Discovery Market: Pestle Analysis
3.4 Global AI in Drug Discovery Market: Porter’s Analysis
Chapter 4 Global AI in Drug Discovery Market: Application Estimates &Trend Analysis
4.1 AI in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 – 2027 (USD Million)
4.3 Preclinical Testing
4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 – 2027 (USD Million)
4.4 Others
4.4.1Others Market Estimates And Forecasts, 2016 – 2027 (USD Million)
Chapter 5 Global AI in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1 AI in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Oncology Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.3 Neurodegenerative Diseases
5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.4 Cardiovascular Disease
5.4.1 Cardiovascular Disease Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.5 Metabolic Diseases
5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.6 Infectious Disease
5.6.1 Infectious Disease Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.7 Others
5.7.1 Others Market Estimates And Forecasts, 2016 – 2027 (USD Million)
Chapter 6 Global AI in Drug Discovery Market: Regional Estimates & Trend Analysis
6.1 Global AI in Drug Discovery Market Movement Analysis, By region
6.2 Global AI in Drug Discovery Market Share, By Region, 2019 & 2027
6.3 North America
6.3.1 North America AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.3.2 The U.S.
6.3.2.1 The U.S. AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.3.3 Canada
6.3.3.1 Canada AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4 Europe
6.4.1 Europe AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4.2 The U.K.
6.4.2.1 U.K. AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4.3 Germany
6.4.3.1 Germany AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4.4 France
6.4.4.1 France AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4.5 Spain
6.4.5.1 Spain AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4.6 Italy
6.4.6.1 Italy AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4.7 Russia
6.4.7.1 Russia AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5 Asia Pacific
6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5.2 China
6.5.2.1 China AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5.3 India
6.5.3.1 India AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5.4 Japan
6.5.4.1 Japan AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5.5 Australia
6.5.5.1 Australia AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5.6 Singapore
6.5.6.1 Singapore AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5.7 South Korea
6.5.7.1 South Korea AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.6 Latin America
6.6.1 Latin America AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.6.2 Brazil
6.6.2.1 Brazil AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.6.3 Mexico
6.6.3.1 Mexico AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.6.4 Argentina
6.6.4.1 Argentina AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.7 MEA
6.7.1 MEA AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.7.2 South Africa
6.7.2.1 South Africa AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.7.3 Saudi Arabia
6.6.3.1 Saudi Arabia AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.7.4 UAE
6.7.4.1 UAE AI in Drug Discovery Market Estimates And Forecasts, 2016 – 2027 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3. Competitive Dashboard & Company Market Position Analysis
7.3.1Synergy Analysis: Major Deals & Strategic Alliances
7.3.2List Of Key Emerging Companies /TechnologyDisruptors/Innovators
Chapter 8 Competitive Landscape
8.1 IBM Watson
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Offerings
8.1.4 Strategic Initiatives
8.2 Exscientia
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Offerings
8.2.4 Strategic Initiatives
8.3 GNS Healthcare.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Offerings
8.3.4 Strategic Initiatives
8.4 Alphabet (DeepMind)
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Offerings
8.4.4 Strategic Initiatives
8.5 Benevolent AI
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Offerings
8.5.4 Strategic Initiatives
8.6 BioSymetrics
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Offerings
8.6.4 Strategic Initiatives
8.7 Euretos.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Offerings
8.7.4 Strategic Initiatives
8.8 Berg Health
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Offerings
8.8.4 Strategic Initiatives
8.9 Atomwise
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Offerings
8.9.4 Strategic Initiatives
8.10 Insitro
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Offerings
8.10.4 Strategic Initiatives
8.11 Cyclica
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Offerings
8.11.4 Strategic Initiatives

List of Tables

Table 1 Partial list of secondary sources
Table 2 North America AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 3 North America AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 4 The U.S. AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 5 The U.S. AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 6 Canada AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 7 Canada AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 8 Europe AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 9 Europe AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 10 The U.K. AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 11 The U.K. AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 12 Germany AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 13 Germany AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 14 France AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 15 France AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 16 Spain AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 17 Spain AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 18 Italy AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 19 Italy AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 20 Russia AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 21 Russia AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 22 Asia Pacific AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 23 Asia Pacific AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 24 China AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 25 China AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 26 India AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 27 India AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 28 Japan AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 29 Japan AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 30 Australia AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 31 Australia AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 32 Singapore AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 33 Singapore AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 34 South Korea AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 35 South Korea AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 36 Latin America AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 37 Latin America AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 38 Brazil AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 39 Brazil AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 40 Mexico AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 41 Mexico AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 42 Argentina AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 43 Argentina AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 44 Middle East & Africa AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 45 Middle East & Africa AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 46 South Africa AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 47 South Africa AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 48 Saudi Arabia AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 49 Saudi Arabia AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)
Table 50 UAE AI drug discovery market, by application, 2016 - 2027 (USD Million)
Table 51 UAE AI drug discovery market, by therapeutic area, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Global AI in drug discovery market snapshot, 2019 (USD Million)
Fig. 9 Global AI in drug discovery market segmentation
Fig. 10 Global AI in drug discovery market dynamics
Fig. 11 Global AI in drug discovery market driver impact
Fig. 12 Global AI in drug discovery market restraints impact
Fig. 13 Global AI in drug discovery market - PESTLE analysis
Fig. 14 Global AI in drug discovery market - Porter’s Analysis
Fig. 15 Global AI in drug discovery market - Application outlook and key takeaways
Fig. 16 Global AI in drug discovery market - Application movement analysis
Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 18 Preclinical testing market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 19 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 20 Global AI in drug discovery market - Therapeutic area outlook and key takeaways
Fig. 21 Global AI in drug discovery market - Therapeutic area movement analysis
Fig. 22 Oncology market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 24 Cardiovascular Disease market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 25 Metabolic Diseases market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 26 Infectious Disease market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 27 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 28 Global AI in drug discovery market - Regional outlook and key takeaways
Fig. 29 Global AI in drug discovery market - Regional movement analysis
Fig. 30 North America AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 31 The U.S. AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 32 Canada AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 33 Europe AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 34 The U.K. AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 35 Germany AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 36 France AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 37 Spain AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 38 Italy AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 39 Russia AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 40 Asia Pacific AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 41 China AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 42 India AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 43 Japan AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 44 Australia AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 45 Singapore AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 46 South Korea AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 47 Latin America AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 48 Brazil AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 49 Mexico AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 50 Argentina AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 51 Middle East & Africa AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 52 South Africa AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 53 Saudi Arabia AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 54 UAE AI in drug discovery estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 55 Recent Developments & Impact Analysis, By Key Market Participants
Fig. 56 Company market position analysis, 2019
Fig. 57 Strategic alliance and deals analysis

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[創薬におけるAIの世界市場2020-2027:治療領域別(腫瘍、心血管疾患、代謝性疾患)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆